{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:51:35Z","timestamp":1790243495456,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique (CNRS)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ejmech.2017.10.060","type":"journal-article","created":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T23:01:03Z","timestamp":1508799663000},"page":"1635-1643","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["Synthesis, characterization, and antileishmanial activity of neutral N-heterocyclic carbenes gold(I) complexes"],"prefix":"10.1016","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3562-1064","authenticated-orcid":false,"given":"Chen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Bourgeade Delmas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Fern\u00e1ndez \u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Valentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Hemmert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Gornitzka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejmech.2017.10.060_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.ejmech.2017.10.060_bib2","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2174\/1389200217666160819161444","article-title":"Current therapeutics, their problems and thiol metabolism as potential drug targets in leishmaniasis","volume":"17","author":"Singh","year":"2016","journal-title":"Curr. Drug Metab."},{"issue":"5","key":"10.1016\/j.ejmech.2017.10.060_bib3","doi-asserted-by":"crossref","first-page":"730","DOI":"10.2174\/1389557511313050010","article-title":"Quinolines as chemotherapeutic agents for leishmaniasis","volume":"13","author":"Reynolds","year":"2013","journal-title":"Mini. Rev. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2017.10.060_bib4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1517\/13543784.2014.954035","article-title":"Investigational drugs for visceral leishmaniasis","volume":"24","author":"Sundar","year":"2015","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.ejmech.2017.10.060_bib5","first-page":"892817","article-title":"Development of vaccines against visceral leishmaniasis","author":"Evans","year":"2012","journal-title":"J.\u00a0Trop. Med."},{"key":"10.1016\/j.ejmech.2017.10.060_bib6","first-page":"69","article-title":"Vaccines for canine leishmanisis","volume":"3","author":"Palatnik-de-Souza","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2017.10.060_bib7","series-title":"Bioinorganic Medicinal Chemistry","author":"Alessio","year":"2011"},{"key":"10.1016\/j.ejmech.2017.10.060_bib8","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ejmech.2014.08.026","article-title":"Triazolopyrimidine compounds containing first-row transition metals and their activity against the neglected infectious Chagas disease and leishmaniasis","volume":"85","author":"Caballero","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2017.10.060_bib9","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00775-015-1239-5","article-title":"Synthesis, characterization and urease inhibition, in\u00a0vitro anticancer and antileishmanial studies of Ni(II) complexes with N, N,N\u2032-trisubstituted thioureas","volume":"20","author":"Rauf","year":"2015","journal-title":"J.\u00a0Biol. Inorg. Chem."},{"key":"10.1016\/j.ejmech.2017.10.060_bib10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ica.2015.12.027","article-title":"Synthesis, characterization and urease inhibition, in\u00a0vitro anticancer and antileishmanial studies of Co(III) complexes with N, N,N\u2032-trisubstituted acylthioureas","volume":"443","author":"Yaseen","year":"2016","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.ejmech.2017.10.060_bib11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.parint.2009.10.006","article-title":"Antileishmanial effect of cisplatin against murine visceral leishmaniasis","volume":"59","author":"Kaur","year":"2010","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.ejmech.2017.10.060_bib12","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s004360050290","article-title":"In\u00a0vitro sensitivity of Leishmania donovani to organometallic derivatives of pentamidine","volume":"83","author":"Mbongo","year":"1997","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ejmech.2017.10.060_bib13","series-title":"Programmed Cell Death in Protozoa","first-page":"59","author":"Navarro","year":"2008"},{"key":"10.1016\/j.ejmech.2017.10.060_bib14","series-title":"Metal-based Therapeutics for Leishmaniasis","first-page":"1","author":"Caballero","year":"2014"},{"key":"10.1016\/j.ejmech.2017.10.060_bib15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jorganchem.2014.08.007","article-title":"Importance of metal complexes for development of potential leishmanicidal agents","volume":"770","author":"Tahghighi","year":"2014","journal-title":"J.\u00a0Organomet. Chem."},{"key":"10.1016\/j.ejmech.2017.10.060_bib16","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00775-002-0427-2","article-title":"Design of copper DNA intercalators with leishmanicidal activity","volume":"8","author":"Navarro","year":"2003","journal-title":"J.\u00a0Biol. Inorg. Chem."},{"key":"10.1016\/j.ejmech.2017.10.060_bib17","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0162-0134(03)00290-3","article-title":"Synthesis, characterization, DNA binding study and biological activity against Leishmania mexicana of [Cu(dppz)2]BF4","volume":"97","author":"Navarro","year":"2003","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2017.10.060_bib18","first-page":"600","article-title":"New silver polypyridyl complexes: synthesis, characterization and biological activity on Leishmania mexicana","volume":"56","author":"Navarro","year":"2006","journal-title":"Arzneim. Forsch.\/Drug Res."},{"key":"10.1016\/j.ejmech.2017.10.060_bib19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jinorgbio.2006.08.015","article-title":"Synthesis and characterization of [Au(dppz)2]Cl3. DNA interaction studies and biological activity against Leishmania (L) mexicana","volume":"101","author":"Navarro","year":"2007","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2017.10.060_bib20","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jinorgbio.2009.02.011","article-title":"Synthesis and characterization of a pyridine-2-thiol N-oxide gold(I) complex with potent antiproliferative effect against Trypanosoma cruzi and Leishmania sp. insight into its mechanism of action","volume":"103","author":"Vieites","year":"2009","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2017.10.060_bib21","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1093\/emboj\/16.10.2590","article-title":"Disruption of the trypanothione reductase gene of Leishmania decreases its ability to survive oxidative stress in macrophages","volume":"16","author":"Dumas","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2017.10.060_bib22","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00726-011-0997-9","article-title":"A\u00a0gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition","volume":"42","author":"Ilari","year":"2012","journal-title":"Amino Acids"},{"key":"10.1016\/j.ejmech.2017.10.060_bib23","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1021\/jm900185q","article-title":"Molecular basis of antimony treatment in leishmaniasis","volume":"52","author":"Baiocco","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.060_bib24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejmech.2014.07.086","article-title":"Synthesis, structures, and selective toxicity to cancer cells of gold(I) complexes involving N-heterocyclic carbene ligands","volume":"85","author":"Boselli","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.060_bib25","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejmech.2012.11.038","article-title":"Synthesis, structures, and antimalarial activities of some silver(I), gold(I) and gold(III) complexes involving N-heterocyclic carbene ligands","volume":"60","author":"Hemmert","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.060_bib26","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1016\/j.bmc.2016.05.023","article-title":"Antiplasmodial activities of gold(I) complexes involving functionalized N-heterocyclic carbenes","volume":"24","author":"Hemmert","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.060_bib27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejmech.2015.02.046","article-title":"Synthesis, structures, and antileishmanial activities of gold(I) complexes involving quinoline functionalized N-heterocyclic carbenes","volume":"94","author":"Paloque","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.060_bib28","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1039\/c0dt00932f","article-title":"Dissymmetric gold(I) N-heterocyclic carbene complexes: a key unexpected structural parameter for highly efficient catalysts in the addition of alcohols to internal alkynes","volume":"40","author":"Bouhrara","year":"2011","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmech.2017.10.060_bib29","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1021\/cr8005153","article-title":"Coinage metal\u2212N-heterocyclic carbene complexes","volume":"109","author":"Lin","year":"2009","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2017.10.060_bib30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10534-014-9703-1","article-title":"Gold complexes with benzimidazole derivatives: synthesis, characterization and biological studies","volume":"27","author":"Mota","year":"2014","journal-title":"Biometals"},{"key":"10.1016\/j.ejmech.2017.10.060_bib31","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.ejmech.2016.10.052","article-title":"Novel gold(I) complexes with 5-phenyl-1,3,4-oxadiazole-2-thione and phosphine as potential anticancer and antileishmanial agents","volume":"127","author":"Chaves","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2017.10.060_bib32","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.cbpa.2010.03.023","article-title":"New antileishmanial candidates and lead compounds","volume":"14","author":"Richard","year":"2010","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ejmech.2017.10.060_bib33","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.drudis.2013.08.005","article-title":"Novel therapeutic strategies for treatment of visceral leishmaniasis","volume":"18","author":"Jain","year":"2013","journal-title":"Drug. Discov. Today"},{"issue":"22","key":"10.1016\/j.ejmech.2017.10.060_bib34","doi-asserted-by":"crossref","first-page":"7155","DOI":"10.1016\/j.bmc.2013.09.002","article-title":"Targeting the human parasite Leishmania donovani: discovery of a new promising anti-infectious pharmacophore in 3-nitroimidazo[1,2-a]pyridine series","volume":"21","author":"Castera-Ducros","year":"2013","journal-title":"Biorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.060_bib35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejmech.2012.04.029","article-title":"Discovery of a new antileishmanial hit in 8-nitroquinoline series","volume":"54","author":"Paloque","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.10.060_bib36","doi-asserted-by":"crossref","first-page":"10369","DOI":"10.1021\/cr400552x","article-title":"Fruitful decade for antileishmanial compounds from 2002 to late 2011","volume":"114","author":"Hussain","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2017.10.060_bib37","article-title":"A\u00a0clinical trial of dextromoramide, (R 875, SKF d-5137)","volume":"8","author":"Lasagna","year":"1958","journal-title":"J.\u00a0Chronic Dis."},{"key":"10.1016\/j.ejmech.2017.10.060_bib38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1586\/14787210.2.1.51","article-title":"A\u00a0review of linezolid: the first oxazolidinone antibiotic","volume":"2","author":"Stevens","year":"2004","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"10","key":"10.1016\/j.ejmech.2017.10.060_bib39","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJMoa0810699","article-title":"Gefitinib or carboplatin\u2013paclitaxel in pulmonary adenocarcinoma","volume":"361","author":"Mok","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2017.10.060_bib40","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1039\/C3CS60015G","article-title":"Recent advances in the synthesis of pyrroles by multicomponent reactions","volume":"43","author":"Estevez","year":"2014","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2017.10.060_bib41","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1107\/S0108767390000277","article-title":"Foundations of crystallography","volume":"A46","author":"Sheldrick","year":"1990","journal-title":"Acta Crystallogr."},{"key":"10.1016\/j.ejmech.2017.10.060_bib42","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1107\/S0108767307043930","article-title":"A\u00a0short history of SHELX","volume":"A64","author":"Sheldrick","year":"2008","journal-title":"Acta Crystallogr."},{"issue":"4","key":"10.1016\/j.ejmech.2017.10.060_bib43","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1128\/AAC.45.4.1168-1173.2001","article-title":"DNA transformation of Leishmania infantum axenic amastigotes and their use in drug screening","volume":"45","author":"Sereno","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.ejmech.2017.10.060_bib44","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1055\/s-0029-1186192","article-title":"Anti-leishmanial lindenane sesquiterpenes from Hedyosmum angustifolium","volume":"76","author":"Acebey","year":"2010","journal-title":"Planta Med."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417308620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417308620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T21:31:50Z","timestamp":1540416710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523417308620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":44,"alternative-id":["S0223523417308620"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.10.060","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis, characterization, and antileishmanial activity of neutral N-heterocyclic carbenes gold(I) complexes","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.10.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}